Combination Therapy for Uncontrolled Hypertension

Rationale for Combination Therapy

The American College of Cardiology recommends adding a medication from a different class, such as a beta blocker, when monotherapy with an angiotensin II receptor blocker (ARB) like telmisartan fails to achieve adequate blood pressure control 3
Beta blockers like propranolol are considered appropriate add-on agents for patients with uncontrolled hypertension, particularly when the initial therapy with an ARB is insufficient 1, 2
The 2017 ACC/AHA guidelines specifically list beta blockers as secondary agents that can be combined with primary agents like ARBs when blood pressure remains uncontrolled 2

The usual dose range for propranolol is 80-160 mg/day divided into 2 doses, so starting with 10mg is a conservative approach that minimizes the risk of side effects 2
Propranolol can be initiated at 1mg IV over 1 minute and titrated up to oral doses as needed for blood pressure control 5
Telmisartan 40mg is within the recommended dosing range of 20-80mg daily 2

Monitor for potential side effects of beta blockers, including hypotension 3, bradycardia 5, bronchospasm (especially in patients with reactive airway disease) 1, and worsening heart failure 1, 2
Assess blood pressure response within 3-4 weeks after adding propranolol to determine if the combination is effective 6

If beta blockers are contraindicated or not tolerated, other options for combination therapy with telmisartan include calcium channel blockers (particularly dihydropyridines like amlodipine) 3, thiazide or thiazide-like diuretics (chlorthalidone, hydrochlorothiazide) 3, 4, and aldosterone antagonists (spironolactone, eplerenone) for resistant hypertension 3

Avoid abrupt cessation of propranolol as this can lead to rebound hypertension or exacerbation of angina 2
Beta blockers are not recommended as first-line agents for hypertension unless the patient has specific indications like ischemic heart disease or heart failure 2
Never combine two ARBs together as this increases risk without providing additional benefit 4